Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study Evaluating AHB-137 in Healthy Participants and Participants with Chronic Hepatitis B
Phase 1
Completed
- Conditions
- Chronic Hepatitis B
- Interventions
- Drug: AHB-137 injectionDrug: Placebo
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- AusperBio Therapeutics Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT05717686
- Locations
- 🇺🇸
Stanford Medicine, Redwood City, California, United States
🇺🇸University of Maryland Baltimore, Baltimore, Maryland, United States
🇺🇸NYU Langone Health, New York, New York, United States
News
No news found